Wave Life Sciences WVE
NASDAQ WVE
$3.40 -0.01 (-0.15%)
As of: Nov 11, 2026 · 11:50 AM EST

Wave Life Sciences (WVE) Net Equity Issued and Repurchased (2015 - 2026)

Updated

Wave Life Sciences (WVE) posted Net Equity Issued and Repurchased of $330,000 for Q2 2026, down 44.4% from $594,000 a year earlier and down 86.9% from the prior quarter.

Analysis

Wave Life Sciences (WVE) Net Equity Issued and Repurchased (2015 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Wave Life Sciences was $15.12 million; for FY2025, it came in at $15.75 million, up 332.9% from FY2024.

  • Annual Net Equity Issued and Repurchased has increased for three consecutive years, though with a five-year compound annual growth rate of -30.1% (FY2020 to FY2025).
  • In prior years, Wave Life Sciences' Net Equity Issued and Repurchased was $3.64 million in FY2024 (+189.4%), $1.26 million in FY2023 (+111.3%), $595,000 in FY2022 (-30.7%) and $858,000 in FY2021 (-99.1%).
  • The Q2 2026 figure stands as the lowest quarterly Net Equity Issued and Repurchased since Q4 2024.
  • On a year-over-year basis, Net Equity Issued and Repurchased increased in 1 of the last five quarters, with growth averaging 44.9%.
  • The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q2 2025, with growth of 460.4%; the weakest was Q2 2023, with a decline of 99.9%.
  • According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $2.53 million (Q1 2026), $9.78 million (Q4 2025) and $2.48 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Wave Life Sciences 672.50 Mn -1.27 Bn - 433,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 433,000.00
Jun 30, 2026 330,000.00
Mar 31, 2026 2.53 Mn
Dec 31, 2025 -32.79 Mn
Sep 30, 2025 45.05 Mn
Jun 30, 2025 594,000.00
Mar 31, 2025 2.89 Mn
Dec 31, 2024 -199.98 Mn
Sep 30, 2024 189.00 Mn
Jun 30, 2024 106,000.00
Mar 31, 2024 14.51 Mn
Dec 31, 2023 388,000.00
Sep 30, 2023 354,000.00
Jun 30, 2023 85,000.00
Mar 31, 2023 430,000.00
Dec 31, 2022 -65.37 Mn
Sep 30, 2022 -45,000.00
Jun 30, 2022 65.80 Mn
Mar 31, 2022 211,000.00
Sep 30, 2021 322,000.00
API Access

Wave Life Sciences Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=WVE&period=max&api_key=YOUR_API_KEY